Spectral AI, Inc. Form 8-K Summary
Business Context and Reporting Period
Spectral AI, Inc. filed a Form 8-K dated April 1, 2024, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing concerns a management appointment and does not report results for a quarterly or annual financial period.
Key Financial and Operating Information
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial performance metrics.
- Jeremiah Sparks was appointed Chief Commercial Officer.
- Mr. Sparks will receive an annual base salary of $295,000 and is eligible for an annual discretionary bonus of up to 30% of base salary.
- He will receive an option to acquire 30,000 shares of common stock, vesting in three annual installments.
Material Changes and Management Commentary
The principal reported change is the appointment of Mr. Sparks as Chief Commercial Officer. The company highlighted his prior seven-year tenure at Avita Medical, Inc. and experience in commercialization, marketing, health economics, reimbursement strategy, and implementation.
Outlook, Risks, Contingencies, and Unusual Items
The filing does not provide financial guidance, operational forecasts, material risks, contingencies, or unusual financial items. The compensation package and equity option grant represent the principal disclosed commitments.
Important Facts to Verify
- Confirm the effective date and scope of Mr. Sparks’s Chief Commercial Officer responsibilities.
- Review the terms of the 30,000-share option, including exercise price and other grant conditions, which are not specified in the filing text.
- Assess the potential cash compensation cost and equity dilution associated with the appointment.
- Review Exhibit 99.1, the April 1, 2024 press release, for any additional management commentary.